Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Willand

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
European Journal of Medicinal Chemistry|July 9, 2023
Recent advances in Fragment-based strategies against tuberculosisBaptiste Villemagne, Léo Faion, Salia Tangara, et al.
Organic & Biomolecular Chemistry|August 22, 2003
Carbohydrate-protein interactions at interfaces: synthesis of thiolactosyl glycolipids and design of a working model for surface plasmon resonancePeter Critchley, M Nicolas Willand, Atvinder K Rullay, et al.
Chemical Biology & Drug Design|June 17, 2008
Natural compounds: leads or ideas? Bioinspired molecules for drug discoveryTerence Beghyn, Rebecca Deprez-Poulain, Nicolas Willand, et al.
European Journal of Medicinal Chemistry|June 21, 2011
Application of Ullmann and Ullmann-Finkelstein reactions for the synthesis of N-aryl-N-(1H-pyrazol-3-yl) acetamide or N-(1-aryl-1H-pyrazol-3-yl) acetamide derivatives and pharmacological evaluationRebecca Deprez-Poulain, Nicolas Cousaert, Patrick Toto, et al.
European Journal of Medicinal Chemistry|May 7, 2023
Antibiotics with novel mode of action as new weapons to fight antimicrobial resistanceFrancesca Ruggieri, Nina Compagne, Kevin Antraygues, et al.
Drug Discovery Today|November 30, 2020
Desirable drug-drug interactions or when a matter of concern becomes a renewed therapeutic strategyBenjamin Guieu, Jean-Pierre Jourdan, Aurore Dreneau, et al.
European Journal of Medicinal Chemistry|March 17, 2012
Tuberculosis: the drug development pipeline at a glanceBaptiste Villemagne, Céline Crauste, Marion Flipo, et al.
Bioanalysis|June 18, 2011
MALDI imaging techniques dedicated to drug-distribution studiesDavid Bonnel, Raphael Legouffe, Nicolas Willand, et al.
Journal of Structural Biology|March 28, 2024
Crystal structure of the Mycobacterium tuberculosis VirS regulator reveals its interaction with the lead compound SMARt751Camille Grosse, Maud Sigoillot, Véronique Megalizzi, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
A Three-Step Process to Isolate Large Quantities of Bioactive Sesquiterpene Lactones from <i>Cichorium intybus</i> L. Roots and Semisynthesis of Chicory STLs StandardsFrancesca Ruggieri, Philippe Hance, Bruna Gioia, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
European Journal of Medicinal Chemistry|July 9, 2023
Recent advances in Fragment-based strategies against tuberculosisBaptiste Villemagne, Léo Faion, Salia Tangara, et al.
Organic & Biomolecular Chemistry|August 22, 2003
Carbohydrate-protein interactions at interfaces: synthesis of thiolactosyl glycolipids and design of a working model for surface plasmon resonancePeter Critchley, M Nicolas Willand, Atvinder K Rullay, et al.
Chemical Biology & Drug Design|June 17, 2008
Natural compounds: leads or ideas? Bioinspired molecules for drug discoveryTerence Beghyn, Rebecca Deprez-Poulain, Nicolas Willand, et al.
European Journal of Medicinal Chemistry|June 21, 2011
Application of Ullmann and Ullmann-Finkelstein reactions for the synthesis of N-aryl-N-(1H-pyrazol-3-yl) acetamide or N-(1-aryl-1H-pyrazol-3-yl) acetamide derivatives and pharmacological evaluationRebecca Deprez-Poulain, Nicolas Cousaert, Patrick Toto, et al.
European Journal of Medicinal Chemistry|May 7, 2023
Antibiotics with novel mode of action as new weapons to fight antimicrobial resistanceFrancesca Ruggieri, Nina Compagne, Kevin Antraygues, et al.
Drug Discovery Today|November 30, 2020
Desirable drug-drug interactions or when a matter of concern becomes a renewed therapeutic strategyBenjamin Guieu, Jean-Pierre Jourdan, Aurore Dreneau, et al.
European Journal of Medicinal Chemistry|March 17, 2012
Tuberculosis: the drug development pipeline at a glanceBaptiste Villemagne, Céline Crauste, Marion Flipo, et al.
Bioanalysis|June 18, 2011
MALDI imaging techniques dedicated to drug-distribution studiesDavid Bonnel, Raphael Legouffe, Nicolas Willand, et al.
Journal of Structural Biology|March 28, 2024
Crystal structure of the Mycobacterium tuberculosis VirS regulator reveals its interaction with the lead compound SMARt751Camille Grosse, Maud Sigoillot, Véronique Megalizzi, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
A Three-Step Process to Isolate Large Quantities of Bioactive Sesquiterpene Lactones from <i>Cichorium intybus</i> L. Roots and Semisynthesis of Chicory STLs StandardsFrancesca Ruggieri, Philippe Hance, Bruna Gioia, et al.
Pageof 5